Accelerate Diagnostics Basic EPS 2010-2024 | AXDXQ
Accelerate Diagnostics basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Accelerate Diagnostics Annual Basic EPS | |
|---|---|
| 2024 | $-2.15 |
| 2023 | $-4.94 |
| 2022 | $-7.61 |
| 2021 | $-12.59 |
| 2020 | $-14.00 |
| 2019 | $-15.50 |
| 2018 | $-16.20 |
| 2017 | $-11.80 |
| 2016 | $-12.90 |
| 2015 | $-10.10 |
| 2014 | $-7.10 |
| 2013 | $-4.10 |
| 2012 | $0.00 |
| 2012 | $-4.30 |
| 2011 | $-0.40 |
| 2010 | $0.60 |
| 2009 | $-0.70 |
| Accelerate Diagnostics Quarterly Basic EPS | |
|---|---|
| 2024-12-31 | $-0.32 |
| 2024-09-30 | $-0.59 |
| 2024-06-30 | $-0.50 |
| 2024-03-31 | $-0.74 |
| 2023-12-31 | $-0.32 |
| 2023-09-30 | $0.06 |
| 2023-06-30 | $-2.97 |
| 2023-03-31 | $-1.71 |
| 2022-12-31 | $-1.35 |
| 2022-09-30 | $-1.83 |
| 2022-06-30 | $-2.43 |
| 2022-03-31 | $-2.00 |
| 2021-12-31 | $-3.39 |
| 2021-09-30 | $-1.50 |
| 2021-06-30 | $-3.60 |
| 2021-03-31 | $-4.10 |
| 2020-12-31 | $-3.30 |
| 2020-09-30 | $-3.30 |
| 2020-06-30 | $-3.50 |
| 2020-03-31 | $-3.90 |
| 2019-12-31 | $-4.00 |
| 2019-09-30 | $-3.70 |
| 2019-06-30 | $-3.80 |
| 2019-03-31 | $-4.00 |
| 2018-12-31 | $-4.10 |
| 2018-09-30 | $-4.10 |
| 2018-06-30 | $-4.30 |
| 2018-03-31 | $-3.70 |
| 2017-12-31 | $-2.90 |
| 2017-09-30 | $-3.10 |
| 2017-06-30 | $-3.10 |
| 2017-03-31 | $-2.70 |
| 2016-12-31 | $-3.10 |
| 2016-09-30 | $-3.40 |
| 2016-06-30 | $-3.50 |
| 2016-03-31 | $-2.90 |
| 2015-12-31 | $-2.90 |
| 2015-09-30 | $-2.50 |
| 2015-06-30 | $-2.70 |
| 2015-03-31 | $-2.00 |
| 2014-12-31 | $-2.00 |
| 2014-09-30 | $-2.00 |
| 2014-06-30 | $-1.90 |
| 2014-03-31 | $-1.20 |
| 2013-12-31 | $-1.20 |
| 2013-09-30 | $-1.00 |
| 2013-06-30 | $-1.00 |
| 2013-03-31 | $-0.90 |
| 2012-12-31 | |
| 2012-10-31 | $-0.70 |
| 2012-09-30 | $-1.50 |
| 2012-07-31 | |
| 2012-06-30 | $-0.95 |
| 2012-04-30 | $-0.30 |
| 2012-03-31 | $-0.30 |
| 2012-01-31 | $-0.30 |
| 2011-10-31 | $-0.40 |
| 2011-07-31 | |
| 2011-04-30 | $-0.10 |
| 2011-01-31 | $0.00 |
| 2010-10-31 | $0.10 |
| 2010-07-31 | |
| 2010-04-30 | $-0.30 |
| 2010-01-31 | $-0.40 |
| 2009-10-31 | $-0.40 |
| 2009-07-31 | |
| 2009-04-30 | $-0.20 |
| 2009-01-31 | $-0.20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $171.715B | 20.77 |
| Intuitive Surgical (ISRG) | United States | $168.416B | 69.81 |
| IDEXX Laboratories (IDXX) | United States | $52.008B | 54.13 |
| Edwards Lifesciences (EW) | United States | $45.753B | 30.32 |
| Alcon (ALC) | Switzerland | $42.148B | 28.48 |
| IQVIA Holdings (IQV) | United States | $30.422B | 17.19 |
| DexCom (DXCM) | United States | $29.961B | 44.94 |
| Mettler-Toledo (MTD) | United States | $25.480B | 30.24 |
| STERIS (STE) | Ireland | $23.239B | 24.76 |
| Waters (WAT) | United States | $16.548B | 22.73 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.365B | 0.00 |
| Hologic (HOLX) | United States | $15.109B | 16.37 |
| Penumbra (PEN) | United States | $9.389B | 68.59 |
| Sysmex ADR (SSMXY) | Japan | $8.643B | 27.46 |
| Masimo (MASI) | United States | $7.872B | 26.49 |
| Globus Medical (GMED) | United States | $7.320B | 16.84 |
| Teleflex (TFX) | United States | $5.104B | 8.24 |
| Glaukos (GKOS) | United States | $5.047B | 0.00 |
| TransMedics (TMDX) | United States | $3.956B | 60.13 |
| Integer Holdings (ITGR) | United States | $3.704B | 18.48 |
| LivaNova (LIVN) | United Kingdom | $2.649B | 15.16 |
| Alphatec Holdings (ATEC) | United States | $2.205B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.190B | 0.00 |
| Veracyte (VCYT) | United States | $2.168B | 30.09 |
| Nihon Kohden (NHNKY) | Japan | $1.962B | 23.42 |
| Elekta AB (EKTAY) | Sweden | $1.862B | 16.74 |
| Artivion (AORT) | United States | $1.396B | 77.86 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.64 |
| OPKO Health (OPK) | United States | $0.976B | 0.00 |
| IRadimed (IRMD) | United States | $0.877B | 42.57 |
| Tandem Diabetes Care (TNDM) | United States | $0.778B | 0.00 |
| SiBone (SIBN) | United States | $0.704B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.656B | 0.00 |
| AxoGen (AXGN) | United States | $0.647B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.556B | 4.46 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.498B | 8.80 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.498B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.481B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.378B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.357B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.356B | 84.92 |
| Mesa Laboratories (MLAB) | United States | $0.349B | 8.88 |
| AngioDynamics (ANGO) | United States | $0.347B | 0.00 |
| RxSight (RXST) | United States | $0.317B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.306B | 0.00 |
| NeuroPace (NPCE) | United States | $0.293B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.277B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.277B | 19.14 |
| Neuronetics (STIM) | United States | $0.265B | 0.00 |
| 908 Devices (MASS) | United States | $0.230B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.194B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.184B | 0.00 |
| CVRx (CVRX) | United States | $0.181B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.158B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.149B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.130B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.106B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| InspireMD (NSPR) | United States | $0.100B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.091B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.088B | 0.00 |
| Spectral AI (MDAI) | United States | $0.061B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.048B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.60 |